{"id":3533,"date":"2017-12-05T17:02:33","date_gmt":"2017-12-05T22:02:33","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=3533"},"modified":"2017-12-05T17:02:33","modified_gmt":"2017-12-05T22:02:33","slug":"secondaries-announced-12-5-17","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/secondaries-announced-12-5-17\/","title":{"rendered":"Secondaries Announced 12.5.17"},"content":{"rendered":"

IPO BOUTIQUE CLIENTS\u00a0and\u00a0IPO BOUTIQUE SECONDARY ALERTS CLIENTS\u00a0received ALL this information to their inbox on a\u00a0REAL TIME\u00a0basis.<\/strong><\/h4>\n

If having\u00a0real-time alerts for secondary offerings<\/strong><\/a>\u00a0would be an advantage to you,\u00a0inquire about a subscription today!<\/a><\/p>\n

Our Buy, Neutral or Avoid ratings of the Secondaries below are intended as a recommendation for those who buy Secondaries on a regular basis. For example, this is not to be interpreted as a Buy recommendation in the traditional sense of adding to your stock portfolio; this is a short term (usually one day or opening trade) time period.<\/p>\n

Company: GW Pharmaceuticals
\nSymbol: GWPH
\nPrice: Last Trade $119.41
\nTrade Date: 12\/7
\nShares: 1.9 million ($225m cash raise)
\nUnderwriter(s) : Goldman Sachs, Morgan Stanley, BofA Merrill Lynch, Cowen
\nDescription: They are a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform.
\nRating = Subscription Needed<\/a><\/strong><\/p>\n

Company: Bill Barrett Corporation
\nSymbol: BBG
\nPrice: Last Trade $5.72
\nTrade Date: 12\/6
\nShares: 21 million
\nRe-Offer Range:\u00a0Subscription Needed<\/a><\/strong>
\nUnderwriter(s) : J.P. Morgan
\nDescription: Headquartered in Denver, Colorado, they develop oil and natural gas in the Rocky Mountain region of the United States.
\nRating = Subscription Needed<\/a><\/strong><\/p>\n

Company: Viking Therapeutics, Inc.
\nSymbol: VKTX
\nPrice: Last Trade $2.74
\nTrade Date: 12\/6
\nShares: 4.7 million
\nRe-Offer Range: Subscription Needed<\/a><\/strong>
\nUnderwriter(s) : William Blair
\nDescription: Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class or best-in-class therapies for metabolic and endocrine disorders.
\nRating = Subscription Needed<\/a><\/strong><\/p>\n

Company: Editas Medicine
\nSymbol: EDIT
\nPrice: Last Trade $27.29
\nTrade Date: 12\/6
\nShares: 1.9 million ($50 million)
\nRe-Offer Range: Subscription Needed<\/a><\/strong>
\nUnderwriter(s) : Morgan Stanley
\nDescription: Editas Medicine is a leading genome editing company dedicated to treating patients with genetically-defined diseases by correcting their disease-causing genes.
\nRating = Subscription Needed<\/a><\/strong><\/p>\n

Company: Attunity Ltd.
\nSymbol: ATTU
\nPrice: Last Trade $7.23
\nTrade Date: 12\/6
\nShares: 3.33 million ($20m -$25m)
\nRe-Offer Range: Subscription Needed<\/a><\/strong>
\nUnderwriter(s) : William Blair, Needham, Roth
\nDescription: They are a provider of Big Data management software solutions that enable access, management, sharing and distribution of data across heterogeneous enterprise platforms, organizations and the cloud.
\nRating = Subscription Needed<\/a><\/strong><\/p>\n

Company: Revance Therapeutics, Inc.
\nSymbol: RVNC
\nPrice: Last Trade $34.75
\nTrade Date: 12\/7
\nShares: 5 million ($175 million cash raise)
\nUnderwriter(s) : Goldman Sachs, Cowen
\nDescription: Revance is a clinical-stage biotechnology company focused on the development, manufacturing, and commercialization of novel botulinum toxin products for multiple aesthetic and therapeutic indications.
\nRating = Subscription Needed<\/a><\/strong><\/p>\n

Company: Integer Holdings Corporation – Block
\nSymbol: ITGR
\nPrice: Last Trade $46.40
\nTrade Date: 12\/6
\nShares: 0.9 million
\nRe-Offer Range: Subscription Needed<\/a><\/strong>
\nUnderwriter(s) : Morgan Stanley
\nDescription: Integer Holdings Corporation operates as a medical device outsource manufacturer worldwide.
\nRating = Subscription Needed<\/a><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"

IPO BOUTIQUE CLIENTS\u00a0and\u00a0IPO BOUTIQUE SECONDARY ALERTS CLIENTS\u00a0received ALL this information to their inbox on a\u00a0REAL TIME\u00a0basis. If having\u00a0real-time alerts for secondary offerings\u00a0would be an advantage to you,\u00a0inquire about a subscription today! Our Buy, Neutral or Avoid ratings of the Secondaries below are intended as a recommendation for those who buy Secondaries on a regular basis.[…]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[35],"tags":[1435,953,739,339,1434,674,323],"class_list":["post-3533","post","type-post","status-publish","format-standard","hentry","category-secondary-offerings","tag-attu","tag-bbg","tag-edit","tag-gwph","tag-itgr","tag-rvnc","tag-vktx"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/3533","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=3533"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/3533\/revisions"}],"predecessor-version":[{"id":3534,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/3533\/revisions\/3534"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=3533"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=3533"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=3533"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}